Anti-SARS-CoV-2 RBD Recombinant Antibody(Regdanvimab(CT-P59 ))
-
产品编号
YR1644
-
别名
科研级 Regdanvimab(CT-P59 ), Anti-RBD Recombinant Antibody, Research Grade Regdanvimab(CT-P59 )
-
规格
- 1mg
- 5mg
Alias | 科研级 Regdanvimab(CT-P59 ), Anti-RBD Recombinant Antibody, Research Grade Regdanvimab(CT-P59 ) |
Catalog Number | YR1644 |
Molecular Name | Regdanvimab(CT-P59 ) |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | Human IgG |
Formulation | PBS, pH7.5 |
Background | Regdanvimab is a monoclonal antibody under investigation for the treatment of coronavirus disease 2019 (COVID‑19). |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 150 kDa |
Target | RBD[SARS-CoV-2] |